Respiratory Syncytial Virus Infections - 28 Studies Found Completed : Safety Study of Oral BTA9881 to Treat RSV Infection : Respiratory Syncytial Virus Infections : 2007-07-18 : Drug: BTA9881 Single oral esca Terminated : Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients : Respiratory Syncytial Virus Infections : 2002-03-06 : Drug: Virazole (Ribavirin) Inhalation Solution Completed : Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children : Respiratory Syncytial Virus Infection : 2008-01-03 Completed : A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT : Respiratory Syncytial Virus Infections : 2005-10-04 : Drug: A-60444 Active, not recruiting : Study to Evaluate the Efficacy and Safety of REGN2222, for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants : Respiratory Syncytial Virus Infections : 2014-12-21 : Drug: REGN2222 Drug: Placebo Completed : Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial) : Respiratory Syncytial Virus Infections Infections, Epidemics : 2013-07-26 Completed : Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions : Respiratory Syncytial Virus Infection : 2011-09-12 : Drug: Palivizumab Other Names: ABT-315 Synagis Completed : ALX-0171 Safety Study in Adults With Hyperresponsive Airways : Respiratory Syncytial Virus Infection : 2013-07-24 : Biological: ALX-0171 Escalating dose of ALX-0171 during maximum 3 consecutive days: from 2.1 mg to maxim Completed : Surveillance of Synagis in Korean Pediatric Patients : Respiratory Syncytial Virus Infection : 2011-12-15 Recruiting : Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age : Respiratory Syncytial Virus Infections : 2017-03-23 : Biological: D46/NS2/N/ΔM2-2-HindIII <<< Previous | Next >>>